{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:07:38Z","timestamp":1776406058246,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This research received a specific grant from the \"Direction G\u00e9n\u00e9rale de l\u2019Offre de Soins (DGOS)\" of the French Ministry of Health as part of a clinical pharmacy project call."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00228-026-04026-6","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:39:26Z","timestamp":1774334366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication optimization pathway in surgery: involving general practitioners and patients during hospitalization and up to 45\u00a0days after returning home"],"prefix":"10.1007","volume":"82","author":[{"given":"Gabrielle","family":"De Guio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Petit-Jean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Guendouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Noll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-1584","authenticated-orcid":false,"given":"Bruno","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gourieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"4026_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzw111","author":"B Michel","year":"2016","unstructured":"Michel B, Hemery M, Rybarczyk-Vigouret MC, Wehrl\u00e9 P, Beck M (2016) Drug-dispensing problems community pharmacists face when patients are discharged from hospitals: a study about 537 prescriptions in Alsace. Int J Qual Health Care. https:\/\/doi.org\/10.1093\/intqhc\/mzw111","journal-title":"Int J Qual Health Care"},{"key":"4026_CR2","volume":"20","author":"M Huber","year":"2024","unstructured":"Huber M, Busch AK, Stalder-Ochsner I, Flammer AJ, Schmid-Mohler G (2024) Medication adherence in adults after hospitalization for heart failure: a cross-sectional study. Int J Cardiol Cardiovasc Risk Prev 20:200234","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"4026_CR3","doi-asserted-by":"publisher","unstructured":"Grei\u00dfing C, Buchal P, Kabitz HJ, Schuchmann M, Zantl N, Schiek S, et al. Medication and Treatment Adherence Following Hospital Discharge. Dtsch \u00c4rztebl Int. 2016: https:\/\/doi.org\/10.3238\/arztebl.2016.0749","DOI":"10.3238\/arztebl.2016.0749"},{"issue":"4","key":"4026_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40266-014-0163-7","volume":"31","author":"L Pasina","year":"2014","unstructured":"Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M et al (2014) Medication Non-Adherence Among Elderly Patients Newly Discharged and Receiving Polypharmacy. Drugs Aging 31(4):283\u2013289","journal-title":"Drugs Aging"},{"issue":"1","key":"4026_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10784-9","volume":"24","author":"L Solh Dost","year":"2024","unstructured":"Solh Dost L, Gastaldi G, Schneider MP (2024) Patient medication management, understanding and adherence during the transition from hospital to outpatient care - a qualitative longitudinal study in polymorbid patients with type 2 diabetes. BMC Health Serv Res 24(1):620","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"4026_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40886-017-0057-6","volume":"3","author":"\u00c9 Dufay","year":"2017","unstructured":"Dufay \u00c9, Doerper S, Michel B, Marson CR, Grain A, Liebbe AM et al (2017) High 5s initiative: implementation of medication reconciliation in France a 5 years experimentation. Saf Health 3(1):6","journal-title":"Saf Health"},{"issue":"8","key":"4026_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12603-014-0541-1","volume":"18","author":"N Oubaya","year":"2014","unstructured":"Oubaya N, Mahmoudi R, Jolly D, Zulfiqar AA, Quignard E, Cunin C et al (2014) Screening for frailty in elderly subjects living at home: Validation of the modified Short Emergency Geriatric Assessment (SEGAm) instrument. J Nutr Health Aging 18(8):757\u2013764","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"4026_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P (2014) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213\u2013218","journal-title":"Age Ageing"},{"key":"4026_CR9","doi-asserted-by":"crossref","unstructured":"Darmon P, Bauduceau B, Bourron O, Cosson E, Dib J, Farret A, et al. Prise de position de la Soci\u00e9t\u00e9 Francophone du Diab\u00e8te (SFD) sur les strat\u00e9gies d\u2019utilisation des traitements antihyperglyc\u00e9miants dans le diab\u00e8te de type 2 \u2013 Actualisation 2021. Soci\u00e9t\u00e9 Francophone du Diab\u00e8te; 2021. https:\/\/www.sfdiabete.org\/actualites\/medical-paramedical\/prise-de-position-de-la-sfd-sur-les-strategies-dutilisation-des. Accessed 15 oct. 2025.","DOI":"10.1016\/j.mmm.2021.10.014"},{"key":"4026_CR10","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Parcours du patient adulte pr\u00e9sentant une maladie r\u00e9nale chronique\u202f: d\u00e9finition des indicateurs de qualit\u00e9 du parcours de soins (D\u00e9cision n\u00b0\u202f2021.0255\/DC\/SEVOQSS, 29 septembre 2021). HAS; 2021. Disponible sur: HAS Sites officiels. Accessed 15 oct. 2025."},{"issue":"33","key":"4026_CR11","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104","journal-title":"Eur Heart J"},{"issue":"2","key":"4026_CR12","doi-asserted-by":"publisher","first-page":"2S9","DOI":"10.1016\/S1262-3636(04)72798-6","volume":"30","author":"B Charbonnel","year":"2004","unstructured":"Charbonnel B, Bouhanick B, Le Feuvre C (2004) Recommandations SFC\/ALFEDIAM sur la prise en charge du patient diab\u00e9tique vu par le cardiologue. Diabetes Metab 30(2):2S9-24","journal-title":"Diabetes Metab"},{"issue":"36","key":"4026_CR13","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 45(36):3415\u2013537","journal-title":"Eur Heart J."},{"issue":"5","key":"4026_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.acvd.2013.04.001","volume":"106","author":"O Hanon","year":"2013","unstructured":"Hanon O, Assayag P, Belmin J, Collet JP, Emeriau JP, Fauchier L et al (2013) Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people. Arch Cardiovasc Dis 106(5):303\u2013323","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"4026_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.rhum.2020.07.009","volume":"87","author":"T Pascart","year":"2020","unstructured":"Pascart T, Latourte A, Chal\u00e8s G, Coblentz-Baumann L, Cohen-Solal A, Ea HK et al (2020) Recommandations de la Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie pour la prise en charge de la goutte\u202f: le traitement hypo-uric\u00e9miant. Rev Rhum 87(5):332\u2013341","journal-title":"Rev Rhum"},{"key":"4026_CR16","unstructured":"Developed with the special contribution of: European Association for Cardiovascular Prevention & Rehabilitation, Authors\/Task Force Members, Reiner Z, Catapano AL, De Backer G, Graham I, et al. ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769\u2011818."},{"key":"4026_CR17","doi-asserted-by":"crossref","unstructured":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201181.","DOI":"10.1111\/jgs.18372"},{"key":"4026_CR18","unstructured":"Zuidlaren, The Netherlands: PCNE Foundation; 2020. Pharmaceutical Care Network Europe (PCNE). PCNE Classification for Drug-Related Problems, version 9.1. Accessed 15 jan. 2025."},{"key":"4026_CR19","doi-asserted-by":"crossref","unstructured":"Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;i2893.","DOI":"10.1136\/bmj.i2893"},{"issue":"1","key":"4026_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12877-023-04155-y","volume":"23","author":"P Nizet","year":"2023","unstructured":"Nizet P, Evin A, Brociero E, Vigneau CV, Huon JF (2023) Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review. BMC Geriatr 23(1):428","journal-title":"BMC Geriatr"},{"key":"4026_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.puhe.2024.01.023","volume":"230","author":"B Nichol","year":"2024","unstructured":"Nichol B, Kemp E, Wilson R, Rodrigues AM, Hesselgreaves H, Robson C et al (2024) Establishing an updated consensus on the conceptual and operational definitions of Making Every Contact Count (MECC) across experts within research and practice: an international Delphi Study. Public Health 230:29\u201337","journal-title":"Public Health"},{"issue":"1","key":"4026_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1472-6963-13-296","volume":"13","author":"S Van Houdt","year":"2013","unstructured":"Van Houdt S, Heyrman J, Vanhaecht K, Sermeus W, De Lepeleire J (2013) Care pathways across the primary-hospital care continuum: using the multi-level framework in explaining care coordination. BMC Health Serv Res 13(1):296","journal-title":"BMC Health Serv Res"},{"key":"4026_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1477313","volume":"12","author":"F Scholz","year":"2024","unstructured":"Scholz F, B\u00f6rner N, Schust SA, Schardey J, K\u00fchn F, Renz B et al (2024) Focus on patient perspectives in climate action policies for healthcare. A German survey analysis on what patients are willing to do. Front Public Health 12:1477313","journal-title":"Front Public Health"},{"issue":"1","key":"4026_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/2193-1801-3-413","volume":"3","author":"S Hannou","year":"2014","unstructured":"Hannou S, Rousseau A, Rybarczyk-Vigouret MC, Michel B (2014) Medication in nursing homes in Alsace: a preferential list of drugs obtained by consensus. Springerplus 3(1):413","journal-title":"Springerplus"},{"issue":"4","key":"4026_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00228-016-2188-9","volume":"73","author":"J L\u00f6nnbro","year":"2017","unstructured":"L\u00f6nnbro J, Wallerstedt SM (2017) Clinical relevance of the STOPP\/START criteria in hip fracture patients. Eur J Clin Pharmacol 73(4):499\u2013505","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4026_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","volume":"21","author":"K Ibrahim","year":"2021","unstructured":"Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC (2021) A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr 21(1):258","journal-title":"BMC Geriatr"},{"issue":"4","key":"4026_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s41999-023-00813-x","volume":"14","author":"TJ Welsh","year":"2023","unstructured":"Welsh TJ, Mitchell A (2023) Centrally acting antihypertensives and alpha-blockers in people at risk of falls: therapeutic dilemmas\u2014a clinical review. Eur Geriatr Med 14(4):675\u2013682","journal-title":"Eur Geriatr Med"},{"issue":"2","key":"4026_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/pharmacy6020030","volume":"6","author":"H Javelot","year":"2018","unstructured":"Javelot H, Marquis A, Antoine-Bernard E, Grandidier J, Weiner L, Javelot T et al (2018) Benzodiazepines Withdrawal: Initial Outcomes and Long-Term Impact on Falls in a French Nursing Home. Pharmacy 6(2):30","journal-title":"Pharmacy"},{"issue":"3","key":"4026_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.encep.2021.09.004","volume":"48","author":"H Javelot","year":"2022","unstructured":"Javelot H, Meyer G, Becker G, Post G, Runge V, Pospieszynski P et al (2022) Les \u00e9chelles anticholinergiques\u202f: usage en psychiatrie et mise \u00e0 jour de l\u2019\u00e9chelle d\u2019impr\u00e9gnation anticholinergique. L\u2019Enc\u00e9phale 48(3):313\u2013324","journal-title":"L\u2019Enc\u00e9phale"},{"key":"4026_CR30","unstructured":"https:\/\/www.ameli.fr\/bas-rhin\/pharmacien\/sante-prevention\/accompagnements\/accompagnement-pharmaceutique-patients-chroniques\/bilan-partage-medication. Accessed 15 oct. 2025."},{"key":"4026_CR31","unstructured":"Article R5125\u201133\u20115 of the French Public Health Code. Pharmacien correspondant; 2021 https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000043571870#:~:text=L'officine%20ou%20la%20pharmacie,r%C3%A9sident%20en%20%C3%A9tablissement%20m%C3%A9dico%2Dsocial. Accessed 15 jan. 2025."},{"issue":"1","key":"4026_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12875-025-02849-3","volume":"26","author":"E Clet","year":"2025","unstructured":"Clet E, Essilini A, Cornet C, Joseph JP, Cohidon C, Alla F (2025) Integrating prevention into primary care organizations: a case study in France. BMC Prim Care 26(1):152","journal-title":"BMC Prim Care"},{"key":"4026_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2022.104983","volume":"172","author":"F Ranchon","year":"2023","unstructured":"Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, Moreau-Gaudry A, Bedouch P (2023) Development of artificial intelligence powered apps and tools for clinical pharmacy services: a systematic review. Int J Med Inform 172:104983","journal-title":"Int J Med Inform"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04026-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:37:28Z","timestamp":1776404248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4026"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04026-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and all its amendments were approved by the French Committee for the Protection of Persons of the Southwest Territories. Written informed consent was obtained from all individual participants. The French National Agency for Medicines and Health Products Safety (ANSM) was informed of the ethical approval. Research registration numbers: IDRCB A00391-56 and clinical trial number: NCT04020692.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and informed consent"}},{"value":"Thomas Vogel has received a speaker honorarium from Pfizer and Amgen companies The other authors have no relevant financial or non-financial interests to disclose.The other authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}